Products for Research Use Only
RegisterLogin

IDO-IN-8

CAT: 0804-HY-18770C-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-18770C-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
IDO-IN-8 (NLG-1487) is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted from patent WO WO2012142237A1, compound 1487, has an IC50 of 1-10 μM.
CAS Number
1402837-77-7
Product Name Alternative
NLG-1487
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Indoleamine 2,3-Dioxygenase (IDO)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/IDO-IN-8.html
Purity
99.99
Solubility
Ethanol : 100 mg/mL (ultrasonic)
Smiles
O[C@H](CC1)CC[C@]1([H])[C@@H](O)C[C@H]2N3C(C4=C2C(F)=CC=C4)=CN=C3
Molecular Formula
C18H21FN2O2
Molecular Weight
316.37
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Mautino, et al. Preparation of fused imidazole derivatives as IDO inhibitors. From PCT Int. Appl. (2012), 20121018.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IDO

Related Products

CatalogName
HY-13983-01IDO-IN-7
HY-18770A-01IDO-IN-6
HY-139883IDO-IN-15
HY-110387IDO-IN-9
HY-115122-01IDO-IN-12
HY-142933IDO-IN-16
HY-153764-01IDO-IN-18
HY-79531-01IDO-IN-1
HY-129749IDO-IN-13
HY-16987-01IDO-IN-3

Alternative Products

CatalogName
T11621IDO-IN-8
E8ER1706-94IDO
YP-W101352-01Monkey IDO (IDO) ELISA Kit
YP-W16543-01Human IDO (IDO) ELISA Kit
BA7836-5.1IDO-IN-12
C3211-5IDO-IN-1
B8310-100IDO-IN-2
BA7832-2IDO-IN-3
70R-14148IDO antibody
T11620IDO-IN-6

Popular Products